<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/london-and-amsterdam/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/london-and-amsterdam</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Tue, 21 Apr 2026 17:30:51 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[OCI Global Announces VP Investor Relations &#038; Communications]]></title>
		<link>https://www.thaipr.net/en/business_en/3393759</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 09 Oct 2023 13:24:33 +0700</pubDate>
				<category>business_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/business_en/3393759</guid>

					<description><![CDATA[<p>OCI Global (Euronext: OCI) today announced the appointment of Sarah Rajani as Vice President, Global Investor Relations and Communications, reporting to Group Chief Financial Officer Hassan Badrawi. Ms. Rajani succeeds Hans Zayed who will assume a new role in the Company following a brief period of transition, and after a ten year tenure in Investor Relations. Ms. Rajani [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/business_en/3393759">OCI Global Announces VP Investor Relations &amp; Communications</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Odyssey Announces Agreement to Combine with BenevolentAI]]></title>
		<link>https://www.thaipr.net/en/health_en/3130554</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 07 Dec 2021 08:30:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3130554</guid>

					<description><![CDATA[<p>BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines Combination of BenevolentAI with Odyssey, a €300m Euronext Amsterdam-listed special purpose acquisition company focused on European healthcare and technology, represents the largest European SPAC merger to [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3130554">Odyssey Announces Agreement to Combine with BenevolentAI</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
